It’s a publicly listed company, established in the year of 1996. Headquarters are located in bassels, Switzerland.
Joseph jiminez is the CEO of the company. Pharmaceuticals, generic drugs, over-the-counter drugs, vaccines, diagnostics, contact lenses, animal health are the key area of its specialization. clozapine (Clozaril), diclofenac (Voltaren), carbamazepine (Tegretol), valsartan (Diovan) and imatinib mesylate (Gleevec/Glivec). Additional agents include cyclosporin (Neoral/Sandimmun), letrozole (Femara), methylphenidate (Ritalin), terbinafine (Lamisil), are some of the drugs which are important to be mentioned from the huge product portfolio of the company.
Novartis was marked as the world's second largest drug manufacturing company in 2011. An IMS Health report ranked Novartis as the biggest drug and chemicals manufacturing company in 2012. In March 2015, the company announced BioPharma is done with its acquisition of two Phase cancer-drug candidates; the MEK inhibitor binimetinib (MEK 162) and the BRAF inhibitor encorafenib (LGX818), for $85 million.[Further, the company sold its RNAi portfolio to Arrowhead Research for $10 million and $25 million in stock. To mention it is a highly research driven company, and it has the headquarters of Novartis institute of Biomedical research In Cammbridge, US.
Total No. of Employees 135696
Liked the List? Share
All pharma companies in UK were taken and valuated on the basis of profits and revenues with a weightage of 30% and 70% given respectively.